Nomura Holdings’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.85M Sell
43,713
-173,463
-80% -$11.3M 0.01% 305
2025
Q1
$14.5M Buy
217,176
+3,297
+2% +$221K 0.03% 145
2024
Q4
$11.8M Buy
213,879
+3,255
+2% +$180K 0.02% 211
2024
Q3
$12.6M Buy
+210,624
New +$12.6M 0.03% 163
2019
Q4
Sell
-405,511
Closed -$29.4M 720
2019
Q3
$29.4M Buy
405,511
+30,062
+8% +$2.18M 0.11% 82
2019
Q2
$31.1M Buy
375,449
+95,462
+34% +$7.9M 0.14% 70
2019
Q1
$19.5M Buy
279,987
+209,441
+297% +$14.6M 0.08% 107
2018
Q4
$3.17M Sell
70,546
-206,463
-75% -$9.28M 0.01% 359
2018
Q3
$15.6M Sell
277,009
-33,106
-11% -$1.86M 0.05% 142
2018
Q2
$20.7M Buy
310,115
+28,134
+10% +$1.88M 0.07% 130
2018
Q1
$16.4K Sell
281,981
-2,280
-0.8% -$133 0.03% 159
2017
Q4
$18.3M Buy
284,261
+43,733
+18% +$2.82M 0.03% 141
2017
Q3
$12.6M Buy
240,528
+31,179
+15% +$1.64M 0.03% 145
2017
Q2
$9.74M Buy
209,349
+448
+0.2% +$20.9K 0.02% 194
2017
Q1
$10.4M Buy
208,901
+1,164
+0.6% +$57.7K 0.03% 122
2016
Q4
$12.6M Buy
207,737
+1,346
+0.7% +$81.5K 0.03% 120
2016
Q3
$13.7M Buy
206,391
+25,327
+14% +$1.68M 0.04% 82
2016
Q2
$10.1M Buy
181,064
+178,946
+8,449% +$9.98M 0.03% 95
2016
Q1
$72K Sell
2,118
-164,632
-99% -$5.6M ﹤0.01% 1033
2015
Q4
$7.52M Buy
166,750
+4,237
+3% +$191K 0.02% 120
2015
Q3
$6.48M Buy
162,513
+11,016
+7% +$439K 0.02% 141
2015
Q2
$9.01M Buy
151,497
+2,496
+2% +$148K 0.03% 136
2015
Q1
$9.03M Buy
149,001
+138,589
+1,331% +$8.4M 0.03% 103
2014
Q4
$567K Buy
+10,412
New +$567K ﹤0.01% 885
2013
Q3
Sell
-9,928
Closed -$59K 2217
2013
Q2
$59K Buy
+9,928
New +$59K ﹤0.01% 1971